[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 3 (5-2020) ::
Caspian J Intern Med 2020, 11(3): 310-314 Back to browse issues page
Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
Elnaz Faramarzi * , Nayyer Jaberi , Mostafa Farahbakhsh , Alireza Ostadrahimi , Mohammad Asghari Jafarabadi , Ali Fakhari
Liver and Gastrointestinal Diseases Research center, Tabriz University of Medical sciences,Tabriz, Iran , elnazfaramarzi849@gmail.com
Abstract:   (2951 Views)
Background: This study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medications.
Methods: In this study, 60 volunteer schizophrenic patients were included. At the onset and 6 months after treatment with antipsychotic medications, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weight, waist circumference (WC), and blood pressure were determined. We defined Mets according to ATPIII criteria.
Results: After a 6-month treatment with antipsychotic drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (p<0.05). We found that the percentage of patients with high WC, low HDL levels, and Mets increased after treatment which was statistically significant (p<0.05).
Conclusion: It is recommended that nutritional and lifestyle changes intervention should be implanted for schizophrenic patients undergoing treatment.
Keywords: schizophrenic patients, metabolic syndrome, metabolic syndrome components
Full-Text [PDF 200 kb]   (787 Downloads)    
Type of Study: Original Article | Subject: psychiatry
Received: 2019/08/27 | Accepted: 2020/02/3 | Published: 2020/05/21
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faramarzi E, Jaberi N, Farahbakhsh M, Ostadrahimi A, Asghari Jafarabadi M, Fakhari A. Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication. Caspian J Intern Med 2020; 11 (3) :310-314
URL: http://caspjim.com/article-1-2035-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (5-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4549